An open label SLV308 safety extension to study S308.3.002 in patients with Parkinson’s disease experiencing motor fluctuations. - An extension of the Mondriaan study
- Conditions
- Advanced stage Parkinson's disease with motor fluctuations.
- Registration Number
- EUCTR2006-005183-91-LV
- Lead Sponsor
- Solvay Pharmaceuticals
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 140
Inclusion Criteria
1.Subjects who have signed informed consent for participation in the safety extension study.
2.Subjects who have completed the S308.3.002 trial.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
1.Subjects with medically relevant abnormal findings (electrocardiogram [ECG], physical examination, AEs) at end of the maintenance phase (Visit M3, Week 12 of maintenance) of study S308.3.002.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method